Extranodal NK-T-cell lymphoma other diagnostic studies: Difference between revisions
No edit summary |
Ahmed Younes (talk | contribs) No edit summary |
||
| (8 intermediate revisions by 2 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AS}} | {{CMG}}; {{AE}} {{AS}} | ||
==Overview== | ==Overview== | ||
Other diagnostic studies for | Other diagnostic studies for extranodal NK-T-cell lymphoma include [[PCR]], [[bone marrow aspiration]], [[bone marrow biopsy]], and in situ hybridization.<ref name="cancer.gov">Extranodal NK-/T-cell lymphoma, nasal type. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd530f/. Accessed on February 02, 2016</ref><ref name="Hindawi">Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type. Hindawi Publishing Corporation. http://www.hindawi.com/journals/ah/2010/627401/. Accessed on February 19, 2016 </ref> | ||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
Other diagnostic studies for | Other diagnostic studies for extranodal NK-T-cell lymphoma include:<ref name="cancer.gov">Extranodal NK-/T-cell lymphoma, nasal type. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd530f/. Accessed on February 02, 2016</ref> | ||
* [[PCR]]: to quantify circulating plasma EBV DNA level<ref name="Hindawi">Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type. Hindawi Publishing Corporation. http://www.hindawi.com/journals/ah/2010/627401/. Accessed on February 19, 2016 </ref> | |||
:* A high level of circulating plasma [[EBV]] [[DNA]] has correlated with: | |||
::* High tumor load | |||
::* Extensive disease | |||
::* Poor response to treatment | |||
::* Inferior survival | |||
* [[Bone marrow aspiration]] | * [[Bone marrow aspiration]] | ||
* [[Bone marrow biopsy]] | * [[Bone marrow biopsy]] | ||
* In situ hybridization: to detect [[EBV]] [[RNA]] | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
| Line 16: | Line 22: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Hematology]] | |||
[[Category:Immunology]] | |||
Latest revision as of 22:59, 6 June 2019
|
Extranodal NK-T-cell lymphoma Microchapters |
|
Differentiating Extranodal NK-T-cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Extranodal NK-T-cell lymphoma other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma other diagnostic studies |
|
FDA on Extranodal NK-T-cell lymphoma other diagnostic studies |
|
CDC on Extranodal NK-T-cell lymphoma other diagnostic studies |
|
Extranodal NK-T-cell lymphoma other diagnostic studies in the news |
|
Blogs on Extranodal NK-T-cell lymphoma other diagnostic studies |
|
Risk calculators and risk factors for Extranodal NK-T-cell lymphoma other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Other diagnostic studies for extranodal NK-T-cell lymphoma include PCR, bone marrow aspiration, bone marrow biopsy, and in situ hybridization.[1][2]
Other Diagnostic Studies
Other diagnostic studies for extranodal NK-T-cell lymphoma include:[1]
-
- High tumor load
- Extensive disease
- Poor response to treatment
- Inferior survival
- Bone marrow aspiration
- Bone marrow biopsy
- In situ hybridization: to detect EBV RNA
References
- ↑ 1.0 1.1 Extranodal NK-/T-cell lymphoma, nasal type. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf56e3e27c3994bd530f/. Accessed on February 02, 2016
- ↑ 2.0 2.1 Extranodal Natural-Killer/T-Cell Lymphoma, Nasal Type. Hindawi Publishing Corporation. http://www.hindawi.com/journals/ah/2010/627401/. Accessed on February 19, 2016